Progressive multifocal leukoencephalopathy in a lung transplant recipient

J Heart Lung Transplant. 2003 Aug;22(8):946-50. doi: 10.1016/s1053-2498(02)00804-5.

Abstract

Progressive multifocal leukoencephalopathy (PML) is a sub-acute, demyelinating disease of the brain caused by a human polyomavirus. We describe a patient with the onset of PML 7 months after lung transplantation. The patient was treated with immunosuppressive modulation and cidofovir, a new anti-viral therapy for PML, with stabilization of the symptoms. We also review the 4 additional reports in the literature of PML after heart and lung transplantation. Progressive multifocal leukoencephalopathy may become more prevalent as the population of heart and lung transplantation recipients increases.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Leukoencephalopathy, Progressive Multifocal / diagnosis
  • Leukoencephalopathy, Progressive Multifocal / drug therapy
  • Leukoencephalopathy, Progressive Multifocal / etiology*
  • Lung Transplantation / adverse effects*
  • Male
  • Middle Aged